Certainty in the Critical Moments of Cardiac Care
Delivering rapid, reliable results for cardiac markers, our integrated solution empowers clinicians to make confident decisions when every second counts.
In Cardiac Emergencies, Every Second and Every Result Matters
In the high-stakes environment of an emergency department or cardiac unit, clinical teams are under immense pressure to rapidly diagnose or rule out acute myocardial infarction (AMI). The imperative is clear: reduce diagnostic uncertainty and door-to-result turnaround time (TAT) to improve patient outcomes. Clinical guidelines, such as the ESC 0/1-hour algorithm for high-sensitivity cardiac Troponin, demand not just speed, but uncompromising analytical precision.
Any delay or doubt in a result—a 'black box' test—can have profound consequences. This is the core challenge we exist to solve: providing a transparently reliable diagnostic workflow that replaces uncertainty with verifiable confidence.
From Sample to Certainty: A More Reliable Workflow
Our solution is engineered to seamlessly integrate into your existing emergency care pathway, optimizing for speed, accuracy, and ease of use.
Accelerated Turnaround Time
Quantitative results for key cardiac markers are delivered in minutes at the point of care, enabling faster clinical decision-making.
Reduced Operational Complexity
The intuitive interface of the FIA-1000 analyzer and ready-to-use test cartridges minimize training requirements and reduce the potential for pre-analytical errors.
Enhanced Clinical Confidence
Our system's performance is built on a foundation of manufacturing excellence, ensuring the lot-to-lot consistency critical for serial patient monitoring.
The Evidence for Confidence
Transparency is the shortest path to trust. Explore the verifiable data that underpins the reliability of our cardiac solutions.
Powered by NomoFlow™: The Source of Verifiable Reliability
The clinical performance you see is not an accident; it is the direct result of our AI-driven manufacturing platform, NomoFlow™. For serial testing of cardiac markers where small changes are clinically significant, consistent performance is paramount. NomoFlow™ ensures industry-leading, lot-to-lot consistency (CV < 3%), providing a stable, reliable baseline for every critical measurement. This is how we eliminate the 'black box' and deliver verifiable reliability, from our factory to your patient's bedside.
Explore the NomoFlow™ PlatformExceptional Performance for Critical Markers
Our assays are validated to meet the demanding requirements of emergency cardiac care.
| Marker | Method | Sensitivity | Specificity | Limit of Detection (LoD) |
|---|---|---|---|---|
| cTnI (High-Sensitivity) | Fluorescent Immunoassay | 99.2% | 99.5% | 1.5 ng/L |
| CK-MB | Fluorescent Immunoassay | 98.5% | 99.1% | 0.5 ng/mL |
| Myoglobin | Fluorescent Immunoassay | 99.0% | 98.8% | 2.0 ng/mL |
*Performance data is for illustrative purposes. Please refer to specific product IFU for validated claims.
Case Study: Reducing Troponin Turnaround Time by 35%
In a partnership with a 300-bed urban hospital, the implementation of the reOpenTest point-of-care cardiac solution within their emergency department yielded significant workflow improvements. By decentralizing testing with the FIA-1000 analyzer, the median troponin result TAT was reduced from an average of 58 minutes to 37 minutes—a 35% reduction. This acceleration enabled the clinical team to more rapidly implement care pathways, leading to a measurable decrease in ED length of stay for patients with chest pain and improved adherence to 0/1-hour protocol goals.
Read Full Case StudyOur Cardiac Emergency Portfolio
The core components engineered to deliver this integrated, reliable solution.
FIA-1000 Immunoassay Analyzer
Our compact, easy-to-use fluorescent immunoassay analyzer, providing quantitative results in minutes.
Learn More →Cardiac Panel 3 (cTnI/CK-MB/Myo) Rapid Test
A multiplex panel for the simultaneous detection of key cardiac markers from a single sample.
Learn More →Quantitative cTnI Rapid Test
A high-sensitivity test for quantitative determination of cardiac Troponin I, aiding in the early diagnosis of acute myocardial infarction (AMI).
Learn More →Elevate Your Cardiac Care Pathway
Discover how reOpenTest's integrated, reliable diagnostic solutions can help your institution meet clinical guidelines, improve patient outcomes, and bring certainty to your emergency department.
Consult a Clinical Specialist